Skip to content
What you need to know:Tracking the Covid-19 Vaccine Rollout Around the Globe
Subscriber Only
Business
Prognosis

Pfizer, BioNTech Boost Vaccine Output Goal by More Than 50%

  • Partners expect to produce 2 billion doses as demand surges
  • Companies previously targeted production of 1.3 billion doses
Serbia's Covid-19 Vaccination Programme
Photographer: Oliver Bunic/Bloomberg
Updated on

Pfizer Inc. and BioNTech SE plan to produce 2 billion doses of their Covid-19 vaccine this year, boosting previously expected output by more than 50% in response to surging global demand.

The companies have already agreed to deliver more than 1 billion doses in pacts with various countries, BioNTech said in a presentation at the JP Morgan Healthcare Conference on Monday. The European Union last week sealed a deal to double its supply of Pfizer-BioNTech shots to as many as 600 million, while the U.S. has locked in a total of 200 million doses.